NOUGUES MAXIMO F 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
NOUGUES MAXIMO F
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-01-03$4.18/sh−10,499$43,864→ 100,427 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.13 to $4.1922, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.